Remicade and Breast pain - a phase IV clinical study of FDA data

Summary:

Breast pain is reported as a side effect among people who take Remicade (infliximab), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Methotrexate, and have Ankylosing spondylitis.

The phase IV clinical study analyzes which people have Breast pain when taking Remicade. It is created by eHealthMe based on reports of 222,651 people who have side effects when taking Remicade from the FDA, and is updated regularly.

What is Remicade?

Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 224,011 Remicade users. Check the latest studies of Remicade.

What is Breast pain?

Breast pain is found to be associated with 979 drugs and 1,699 conditions by eHealthMe. Check the latest studies of Breast pain.

On Jul, 10, 2026

222,651 people reported to have side effects when taking Remicade.
Among them, 61 people (0.03%) have Breast pain.

Among these 61 people:

How long have people been on Remicade when they have Breast pain? *

What is the gender of people who have Breast pain when taking Remicade? *

female: 81.97 %
male: 18.03 %

What is the age of people who have Breast pain when taking Remicade? *

What are other drugs people take besides Remicade? *

What are other side effects people have besides Breast pain? *

Fatigue (feeling of tiredness): 7 people, 11.48%
Infusion Related Reaction: 7 people, 11.48%
Breast Swelling: 7 people, 11.48%
Dyspnea (difficult or laboured breathing): 6 people, 9.84%
Pain In Extremity: 6 people, 9.84%
Joint Pain: 6 people, 9.84%
Rashes (redness): 6 people, 9.84%
Headache (pain in head): 6 people, 9.84%
High Blood Pressure: 5 people, 8.20%
Memory Loss: 4 people, 6.56%

What are the existing conditions these people have? *

Ankylosing Spondylitis (type of arthritis affecting the spine): 5 people, 8.20%
Pyoderma Gangrenosum (ulcerating condition of skin that results in heaped borders with a typical appearance): 2 people, 3.28%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 3.28%
High Blood Pressure: 2 people, 3.28%
Uterine Leiomyoma (uterine benign tumour derived from smooth muscle): 1 person, 1.64%
Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 1 person, 1.64%
Prostate Cancer: 1 person, 1.64%
Osteopenia (a condition where bone mineral density is lower than normal): 1 person, 1.64%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 1.64%
Inflammatory Bowel Disease: 1 person, 1.64%

* Approximation only. Some reports may have incomplete information.

Do you take Remicade and have Breast pain?

- Check whether Breast pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Remicade:

Remicade (224,011 reports)

Breast pain treatments and more:

Breast pain (23,879 reports)

Browse all side effects of Remicade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Breast pain:

Breast pain (979 drugs)

Browse all the conditions that are associated with Breast pain:

Breast pain (1,699 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on infliximab (the active ingredients of Remicade) and Remicade (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.